A61P 3/14

Technology



back to "A61P 3/14" profile

More Results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
8653077 Inhibitors of human phosphatidylinositol 3-kinase deltaSep 28, 11Feb 18, 14ICOS CORPORATION
8575090 Amylin analogues and pharmaceutical compositions thereofJun 08, 12Nov 05, 13NOVO NORDISK A/S
8198272 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicamentsAug 05, 10Jun 12, 12SANOFI
8153664 Bicyclic and tricyclic derivatives as thrombin receptor antagonistsOct 02, 07Apr 10, 12MERCK SHARP & DOHME CORP.
8053434 Kinase inhibitors and their usesSep 01, 09Nov 08, 11RIGEL PHARMACEUTICALS, INC.
8048866 Preventive and/or therapeutic agent for calcipeniaAug 13, 04Nov 01, 11NIPPON BEET SUGAR MFG. CO., LTD.
8026272 Modified lysine-mimetic compoundsOct 30, 09Sep 27, 11ZEALAND PHARMA A/S
7829572 )-one derivatives as calcium receptor antagonistsOct 04, 07Nov 09, 10PFIZER INC.
7803795 Phthalazine derivatives as parp inhibitorsJun 28, 05Sep 28, 10JANSSEN PHARMACEUTICA NV
6521615 Diagnosing an animal for pyrophosphate gout, osteoporosis, or osteoarthritis by assaying intracellular pyrophosphate content in peripheral blood cellsJan 04, 01Feb 18, 03THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
6221874 Method of treating bone loss by stimulation of calcitoninMay 03, 99Apr 24, 01WYETH